Significance of platelet‐activating factor acetylhydrolase in patients with non‐insulin‐dependent (type 2) <i>diabetes mellitus</i>

Abstract

Diabetic and dyslipidemic patients have an increased plasma PAF-AH activity correlated with their LDL-ch levels and mainly with LDL-ch / HDL-ch ratio. Plasma PAF-AH high levels appear to be important as a risk marker for endothelial dysfunction in patients with NIDDM.